CHEMET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chemet, and when can generic versions of Chemet launch?
Chemet is a drug marketed by Recordati Rare and is included in one NDA.
The generic ingredient in CHEMET is succimer. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the succimer profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHEMET?
- What are the global sales for CHEMET?
- What is Average Wholesale Price for CHEMET?
Summary for CHEMET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,154 |
| Drug Prices: | Drug price information for CHEMET |
| What excipients (inactive ingredients) are in CHEMET? | CHEMET excipients list |
| DailyMed Link: | CHEMET at DailyMed |
Recent Clinical Trials for CHEMET
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
Pharmacology for CHEMET
| Drug Class | Lead Chelator |
| Mechanism of Action | Lead Chelating Activity |
US Patents and Regulatory Information for CHEMET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare | CHEMET | succimer | CAPSULE;ORAL | 019998-002 | Jan 30, 1991 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
